Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase
about
Cytochrome P450 ω-Hydroxylases in Inflammation and CancerOcular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic dispositionCYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activitiesEvolution of Cellular Inclusions in Bietti's Crystalline DystrophyCYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET)The transcriptional response of Caenorhabditis elegans to Ivermectin exposure identifies novel genes involved in the response to reduced food intakeThe Concise Guide to PHARMACOLOGY 2013/14: enzymes.Molecular analysis and phenotypic study in 14 Chinese families with Bietti crystalline dystrophyIdentification and developmental expression of the full complement of Cytochrome P450 genes in ZebrafishCharacterizing proteins of unknown function: orphan cytochrome p450 enzymes as a paradigm.Generation and characterization of a murine model of Bietti crystalline dystrophyCerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysisNovel insights into the molecular pathogenesis of CYP4V2-associated Bietti's retinal dystrophy.Regulation of the F11, Klkb1, Cyp4v3 gene cluster in livers of metabolically challenged mice.Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states.Orphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology.An atypical form of Bietti crystalline dystrophy.Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5.A Novel Compound Heterozygous Mutation in the CYP4V2 Gene in a Japanese Patient with Bietti's Crystalline Corneoretinal DystrophySeasonal variation in the skin transcriptome of common bottlenose dolphins (Tursiops truncatus) from the northern Gulf of Mexico.Bioactivation of 4-Ipomeanol by a CYP4B enzyme in bovine lung and inhibition by HET0016.CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variantMetabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipidsA genome-wide association meta-analysis on apolipoprotein A-IV concentrations.Approaches to deorphanization of human and microbial cytochrome P450 enzymes.Identification and population history of CYP4V2 mutations in patients with Bietti crystalline corneoretinal dystrophy.Comparative modeling and molecular docking of orphan human CYP4V2 protein with fatty acid substrates: Insights into substrate specificity.Designing and Creating a Synthetic Omega Oxidation Pathway in Saccharomyces cerevisiae Enables Production of Medium-Chain α, ω-Dicarboxylic Acids.Expression and Functional Characterization of Breast Cancer-Associated Cytochrome P450 4Z1 in Saccharomyces cerevisiae.Evolution of CYP2J19, a gene involved in colour vision and red coloration in birds: positive selection in the face of conservation and pleiotropy.20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1.Specific regulation of thermosensitive lipid droplet fusion by a nuclear hormone receptor pathway.CYP4V2 omega-hydroxylates DHA to HDoHEReduction of lipid accumulation rescues Bietti's crystalline dystrophy phenotypes.A novel mutation in the CYP4V2 gene in a Chinese patient with Bietti's crystalline dystrophy.
P2860
Q26800210-4FC4ED8D-9338-4B10-9A06-A7636A7664B2Q26851574-D5F7B0ED-49E7-42B0-9933-90CFA4ADBA84Q28290987-C93E845A-FC39-49F9-97E7-1DCAEC7E744EQ28306236-DBCAB8A0-CD67-4D9F-9C3B-359DD0ED8BBBQ28307304-77F846EC-DDC6-414A-AFCE-B6F9832DAAC7Q28480640-72726D73-0F67-4943-93CC-0C83B713E2E6Q30486745-E4F628DC-FE65-4A48-932C-9BD2F78E30C3Q31158744-1EFFBAE9-CCA6-4094-9303-0950FD7FE8FEQ33750732-F83F5A33-8750-45C9-B79C-44517F1A435CQ33953907-3E3CED04-4735-4184-93F9-B3B8260EC495Q34159536-7E394BCA-C4C6-44B0-9CEB-5C10A1955ABCQ34360732-96F94E5E-A84C-45FF-AE4E-3ACD20E6BFC3Q34987468-D5C545F8-B725-4C45-9839-F528A7E187B4Q34997383-97325C10-AE2D-4339-B959-53770159A3F7Q35030324-F13482E9-A0C3-4884-8D65-EC5764EA50F4Q35122778-49857AC3-E959-4931-AFD7-77517E81C93BQ35163156-F6B5EC5E-719E-42C2-B900-8CFF85029227Q35175018-8F60B29C-C8FA-463A-B418-22B34467E33EQ35545659-A24FA7D7-8BF3-4ED4-9E56-CB9A91068CAFQ35674302-3D3A70E0-0E13-4C6D-B404-3022F995C4C0Q36175877-74288474-7B9A-4614-9568-42209F0583BBQ36294398-123D26BD-6EBD-4722-8DD0-4A832BF304F8Q36520398-8F15ADCF-2F89-411D-A208-CA879F814E54Q37528956-4ABF165E-3E66-40DB-8544-994BDEBB4501Q37759731-74877DCF-4E60-4F55-A324-44517D8AA374Q40397099-5E0C1B01-E2C2-44B3-B94E-73E33D627C6BQ41161216-D98E0F47-D975-4271-9A71-057B7752C8E9Q46973213-EC352E4C-B5B3-404E-9A42-529A3A803EB3Q47824410-D57197D3-56B1-4224-8C1B-3D21D29127E5Q49215504-B440D274-CE31-4494-941B-717A12E0A209Q49549662-83961ED4-AAC9-45ED-9D6F-E58A2E52DE07Q50042983-2769EF79-2271-4F04-B577-CCF101250540Q50295268-6ABEE83B-65BF-41A5-A5AD-57921A9A1E4DQ51734338-D396EE97-9854-4F88-94D9-F9B9A9D980C5Q54279374-787C0484-9E22-4C4D-B942-32D20F707C96
P2860
Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase
@ast
Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase
@en
Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase
@en-gb
Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase
@nl
type
label
Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase
@ast
Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase
@en
Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase
@en-gb
Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase
@nl
prefLabel
Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase
@ast
Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase
@en
Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase
@en-gb
Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase
@nl
P2093
P2860
P921
P3181
P356
P1476
Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase
@en
P2093
Allan E Rettie
Edward J Kelly
Mariko Nakano
P2860
P304
P3181
P356
10.1124/DMD.109.028530
P407
P577
2009-11-01T00:00:00Z